Kiniksa Pharmaceuticals is a commercial-stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most. We are seeking a highly analytical and inquisitive Clinical Scientist to provide analytical support for a high-priority, Global Phase 2/3 pivotal program reporting to the Chief Medical Officer (CMO). This role is responsible for the continuous monitoring of daily clinical trial data, ensuring high-level data integrity, and translating complex data sets into actionable insights. The successful candidate will act as a primary bridge between raw clinical data and clinical decision-making, working in close collaboration with the Chief Medical Officer, Clinical Development Lead, and cross-functional program team. This role is based in our Lexington, MA office and requires employees to be onsite five days per week.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
Ph.D. or professional degree